(Q42372263)

28 October 2017

1 reference

17 November 2019

1 reference

PubMed publication ID

1911179

title

The current status of scientific research and hormonal treatments for carcinoma of the prostate (English)

1 reference

28 October 2017

1 reference

3 April 2019

1 reference

17 November 2019

Waxman J

1 reference

28 October 2017

Saini A

series ordinal

1 reference

28 October 2017

language of work or name

English

0 references

publication date

1 September 1991

3 references

British Journal of Cancer

28 October 2017

3 April 2019

17 November 2019

3 references

28 October 2017

3 April 2019

17 November 2019

1 reference

28 October 2017

1 reference

28 October 2017

419-421

1 reference

Correlation of prostatic nuclear androgen receptor content with duration of response and survival following hormonal therapy in advanced prostatic cancer

28 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977666

Gonadotrophin hormone releasing analogues open new doors in cancer treatment

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977666

Comparison of diethylstilbestrol, cyproterone acetate and medroxyprogesterone acetate in the treatment of advanced prostatic cancer: final analysis of a randomized phase III trial of the European Organization for Research on Treatment of Cancer Urol

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977666

A controlled trial of leuprolide with and without flutamide in prostatic carcinoma

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977666

Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977666

Production and response of a human prostatic cancer line to transforming growth factor-like molecules

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977666

ras gene mutations in human prostate cancer

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977666

The effects of gonadotrophin releasing hormone analogues in prostate cancer are mediated through specific tumour receptors

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977666

Three-monthly GnRH agonist (buserelin) for prostatic cancer

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977666

Epidermal Growth Factor Receptor mRNA Levels in Human Prostatic Tumors and Cell Lines

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977666

Expression of ras oncogene p21 in prostate cancer

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977666

II. The Present Position of the Surgery of the Hypertrophied Prostate

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977666

Combination therapy with flutamide and castration (orchiectomy or LHRH agonist): the minimal endocrine therapy in both untreated and previously treated patients

1 December 2018

1 reference

12 December 2020

Expression of a transfected v-Harvey-ras oncogene in a Dunning rat prostate adenocarcinoma and the development of high metastatic ability

1 reference

12 December 2020

Expression of the c-myc protooncogene in human prostatic carcinoma and benign prostatic hyperplasia

1 reference

12 December 2020

Androgen suppression by hydrocortisone without aminoglutethimide in orchiectomised men with prostatic cancer

1 reference

12 December 2020

Expression of cellular oncogenes in human prostatic carcinoma cell lines

1 reference

12 December 2020

Orchiectomy for advanced prostatic carcinoma A reevaluation

1 reference

12 December 2020

Advanced prostatic carcinoma Flutamide therapy after conventional endocrine treatment

1 reference

12 December 2020

Endocrine control of prostatic carcinoma; clinical and statistical survey of 1,818 cases

1 reference

12 December 2020

Combined versus sequential chemo-endocrine therapy in advanced prostate cancer: final results of a randomized Southwest Oncology Group study

1 reference

12 December 2020

Epidermal growth factor and prostatic carcinoma: an immunohistochemical study

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1991.324

1 reference

28 October 2017

1 reference

28 October 2017

PubMed publication ID

1911179

1 reference